Captrust Financial Advisors Blueprint Medicines Corp Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

A detailed history of Captrust Financial Advisors transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Captrust Financial Advisors holds 17,904 shares of BPMC stock, worth $1.62 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

17,904

Previous 17,322 3.36%

Holding current value

$1.62 Million

Previous $1.87 Million 11.31%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$84.1 - $120.5 $48,946 - $70,131	582 Added 3.36%	17,904 $1.66 Million
Q2 2024 Aug 14, 2024	SELL	$85.18 - $108.78 $664,489 - $848,592	-7,801 Reduced 31.05%	17,322 $1.87 Million
Q1 2024 May 15, 2024	SELL	$73.17 - $99.79 $996,941 - $1.36 Million	-13,625 Reduced 35.16%	25,123 $2.38 Million
Q4 2023 Feb 14, 2024	SELL	$43.96 - $92.84 $559,171 - $1.18 Million	-12,720 Reduced 24.71%	38,748 $3.57 Million
Q3 2023 Nov 14, 2023	BUY	$46.9 - $66.0 $77,994 - $109,758	1,663 Added 3.34%	51,468 $2.58 Million
Q2 2023 Aug 14, 2023	BUY	$42.2 - $66.37 $937,979 - $1.48 Million	22,227 Added 80.6%	49,805 $3.15 Million
Q1 2023 May 15, 2023	BUY	$37.97 - $50.0 $315,758 - $415,800	8,316 Added 43.17%	27,578 $1.24 Million
Q4 2022 Feb 15, 2023	BUY	$41.06 - $66.48 $91,112 - $147,519	2,219 Added 13.02%	19,262 $843,000
Q3 2022 Nov 16, 2022	SELL	$49.93 - $77.7 $1,547 - $2,408	-31 Reduced 0.18%	17,043 $1.12 Million
Q2 2022 Aug 23, 2022	SELL	$45.23 - $70.15 $633 - $982	-14 Reduced 0.08%	17,074 $862,000
Q2 2022 Aug 16, 2022	BUY	$45.23 - $70.15 $39,892 - $61,872	882 Added 5.44%	17,088 $863,000
Q1 2022 May 16, 2022	BUY	$54.1 - $110.08 $21,694 - $44,142	401 Added 2.54%	16,206 $1.04 Million
Q4 2021 Feb 14, 2022	BUY	$94.25 - $115.99 $90,857 - $111,814	964 Added 6.5%	15,805 $1.69 Million
Q3 2021 Nov 16, 2021	BUY	$80.98 - $109.47 $202,692 - $274,003	2,503 Added 20.29%	14,841 $1.53 Million
Q1 2021 May 17, 2021	BUY	$90.71 - $108.28 $11,883 - $14,184	131 Added 1.07%	12,338 $1.2 Million
Q4 2020 Feb 16, 2021	SELL	$92.08 - $124.48 $62,061 - $83,899	-674 Reduced 5.23%	12,207 $1.37 Million
Q2 2020 Aug 14, 2020	BUY	$57.09 - $79.27 $91,344 - $126,832	1,600 Added 14.18%	12,881 $1.02 Million
Q1 2020 May 15, 2020	BUY	$48.11 - $82.22 $3,848 - $6,577	80 Added 0.71%	11,281 $644,000
Q4 2019 Feb 14, 2020	BUY	$66.73 - $82.59 $747,442 - $925,090	11,201 New	11,201 $921,000

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Blueprint Medicines Corp Transaction History